Download free PDF

HIV Rapid Test Kits Market Size - Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2025 - 2034

Report ID: GMI4544

Download Free PDF

HIV Rapid Test Kits Market Size

The global HIV rapid test kits market is expected to grow significantly between 2025 and 2034, driven by an increasing global focus on early and affordable HIV diagnosis. WHO estimates that roughly 39.9 million individuals were living with HIV at the end of 2023, including 1.4 million children (0-14 years) and 38.6 million adults (15 years and above). Through its Global HIV Programme, WHO facilitates the effective integration of hepatitis and sexually transmitted infection prevention, testing, and treatment with services that meet sexual, reproductive, and mental health needs— all of which are required for providing acceptable and effective programs.

Increased awareness campaigns, government programs encouraging early screening, and enhanced access to healthcare are combining to support the market growth. In most nations, mobile clinics, community-based tests, and self-testing programs have picked up pace, having a major impact on the demand for HIV rapid test kits. The increasing incidence of late HIV diagnosis and co-infections such as tuberculosis further highlights the necessity for user-friendly, rapid testing devices. The inclusion of HIV testing in wider health campaigns, such as maternal health and infectious disease screening programs, serves as another central impetus driving the market. The ease of point-of-care (POC) testing, complemented with strong policy support and technological improvement, is establishing the platform for a dynamic growth path over the forecast period.
 

HIV Rapid Test Kits Market Trends

In 2025, the HIV rapid test kits industry is experiencing significant trends that are transforming the scene. The most prominent of them is the popularity of self-test kits. Demand for privacy, convenience, and instant results has prompted manufacturers to develop extremely accurate, intuitive home-based HIV test kits. Manufacturers are further bolstering digital connectivity capabilities by adding app-guided support and telemedicine consultations to provide an end-to-end ecosystem for consumers from test to treatment.
 

The other leading trend is towards fourth-generation quick HIV tests that can identify both HIV-1/2 antibodies and p24 antigen at the same time. These newer tests lower the "window period" between the acquisition of infection and detection, which increases the probability of earlier diagnosis and optimal timing of treatment initiation.
 

Sustainability is also emerging, as firms highlight eco-friendly test kit materials and biodegradable components to lower footprint. As well, partnerships between diagnostic companies and non-profits are expanding to allow access to test kits in low- and middle-income countries for underprivileged populations. The advent of multiplex rapid tests that simultaneously detect HIV together with other STIs such as syphilis and hepatitis is gaining strong momentum. These combination solutions enhance cost savings and patient convenience, targeting the real-world demand for the detection of total diseases at the point of care.
 

HIV Rapid Test Kits Market Analysis

The Nucleic Acid Amplification Test (NAAT) market is expected to register high growth in 2025-2034 as a result of the increased need for accuracy diagnostics. NAAT being a molecular method still boasts unparalleled sensitivity and specificity, thus it remains the gold standard for HIV early detection, particularly in high-risk populations like pregnant women and immunocompromised patients.
 

Latest advances are also refining NAAT technologies for point-of-care use. Miniaturized NAAT platforms coupled with isothermal amplification strategies now facilitate quicker turnaround time with laboratory-quality precision. This is bringing NAAT-based rapid tests within reach even in decentralized and resource-poor environments.
 

Additionally, the cost-effectiveness of NAAT platforms is enhancing through scaling up manufacturing processes and enhanced public-private partnerships. For example, various governments are subsidizing NAAT-based test kits to enhance national HIV testing strategies. With increasing focus on ending undiagnosed infections to achieve 2030 targets, the NAAT segment will remain a key driver in the HIV rapid test kits market.
 

Where sample type is concerned, the blood sample segment is a leading force during the forecast period. But other sample collection methods like dried blood spots (DBS) and oral fluid testing are catching up fast. DBS presents logistical benefits — stable at room temperature and suitable for remote locations — while oral fluid testing delivers a non-invasive, stigma-reducing experience for patients.
 

Significantly, the Centers for Disease Control and Prevention (CDC) of the U.S. has supported the expanded use of self-collected DBS samples in home-testing models, confirming its utility in national HIV surveillance programs. This versatility in sample types facilitates wider use of rapid test kits across different populations, making testing more inclusive and barrier-free.
 

The market for HIV rapid test kits is expected to grow substantially through 2032 due to the improvement of the healthcare infrastructure, public awareness, and an emphasis on preventative healthcare. Increased collaboration between government, healthcare organizations, and private interests is creating an ecosystem that supports the development and access to HIV testing technology with greater access, accuracy, and efficiency- growth of the whole field.
 

HIV Rapid Test Kits Market Share

Major competitors in the market for HIV rapid test kits are:

  • bioMérieux
  • Biosynex
  • Atomo Diagnostics
  • OraSure Technologies
  • Chembio Diagnostic Systems
  • Sedia Biosciences Corporation
  • Biolytical Laboratories
  • Abbott
  • BioSure
  • Hologic
     

The players are securing their places through heavy investments in research, product differentiation, and strategic partnerships. They are also adopting sustainability efforts, minimizing plastic usage, and designing eco-friendly packaging for their rapid test kits to attract socially conscious consumers as well as regulatory agencies.
 

HIV Rapid Test Kits Industry News

Abbott launched its new Panbio™ HIV Self Test in November 2022, which can be purchased over the counter from e-commerce channels in Hong Kong, allowing users to get results anywhere, anytime within 15-20 minutes.
 

In April 2025, Atomo Diagnostics gained a $230,000 order from Thorne Harbour Health to provide its HIV Self Test kits in support of the nationwide roll-out of the CONNECT program of the Australian federal government, providing free HIV self-test kits through vending machines in South Australia and Victoria.
 

Authors:  Monali Tayade

Research methodology, data sources & validation process

This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.

Our 6-step research process

  1. 1. Research design & analyst oversight

    At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.

    Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.

  2. 2. Primary research

    Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.

  3. 3. Data mining & market analysis

    Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.

  4. 4. Market sizing

    Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.

  5. 5. Forecast model & key assumptions

    Every forecast includes explicit documentation of:

    • ✓ Key growth drivers and their assumed impact

    • ✓ Restraining factors and mitigation scenarios

    • ✓ Regulatory assumptions and policy change risk

    • ✓ Technology adoption curve parameter

    • ✓ Macroeconomic assumptions (GDP growth, inflation, currency)

    • ✓ Competitive dynamics and market entry/exit expectations

  6. 6. Validation & quality assurance

    The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.

    Our triple-layer validation process ensures maximum data reliability:

    • ✓ Statistical Validation

    • ✓ Expert Validation

    • ✓ Market Reality Check

Trust & credibility

10+
Years in Service
Consistent delivery since establishment
A+
BBB Accreditation
Professional standards & satisfaction
ISO
Certified Quality
ISO 9001-2015 Certified Company
150+
Research Analysts
Across 10+ industry verticals
95%
Client Retention
5-year relationship value

Verified data sources

  • Trade publications

    Security & defense sector journals and trade press

  • Industry databases

    Proprietary and third-party market databases

  • Regulatory filings

    Government procurement records and policy documents

  • Academic research

    University studies and specialist institution reports

  • Company reports

    Annual reports, investor presentations, and filings

  • Expert interviews

    C-suite, procurement leads, and technical specialists

  • GMI archive

    13,000+ published studies across 30+ industry verticals

  • Trade data

    Import/export volumes, HS codes, and customs records

Parameters studied & evaluated

Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →

Authors:  Monali Tayade,
Explore Our Licensing Options:

Starting at: $2,450

We use cookies to enhance user experience. (Privacy Policy)